ZA200509760B - Composition for maintaining organ and cell viability - Google Patents

Composition for maintaining organ and cell viability

Info

Publication number
ZA200509760B
ZA200509760B ZA200509760A ZA200509760A ZA200509760B ZA 200509760 B ZA200509760 B ZA 200509760B ZA 200509760 A ZA200509760 A ZA 200509760A ZA 200509760 A ZA200509760 A ZA 200509760A ZA 200509760 B ZA200509760 B ZA 200509760B
Authority
ZA
South Africa
Prior art keywords
composition
cell viability
maintaining organ
organ
maintaining
Prior art date
Application number
ZA200509760A
Other languages
English (en)
Inventor
Fischer Joseph
Robert G L Shorr
Baker Jan
Original Assignee
Lifeblood Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32991004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200509760(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lifeblood Medical Inc filed Critical Lifeblood Medical Inc
Publication of ZA200509760B publication Critical patent/ZA200509760B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
ZA200509760A 2003-05-09 2005-12-01 Composition for maintaining organ and cell viability ZA200509760B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46920003P 2003-05-09 2003-05-09

Publications (1)

Publication Number Publication Date
ZA200509760B true ZA200509760B (en) 2006-11-29

Family

ID=32991004

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200509760A ZA200509760B (en) 2003-05-09 2005-12-01 Composition for maintaining organ and cell viability

Country Status (12)

Country Link
US (3) US7220538B2 (fr)
EP (3) EP1475434A1 (fr)
JP (2) JP5192694B2 (fr)
KR (1) KR20060019525A (fr)
CN (2) CN1784142A (fr)
AU (2) AU2004239310B2 (fr)
BR (1) BRPI0410185A (fr)
CA (2) CA2523417C (fr)
MX (1) MXPA05012070A (fr)
RU (1) RU2005138320A (fr)
WO (2) WO2004099393A1 (fr)
ZA (1) ZA200509760B (fr)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1475434A1 (fr) * 2003-05-09 2004-11-10 Oncoscience AG Procédé de stockage de cellules tumorales
US7087369B2 (en) * 2003-12-17 2006-08-08 The Regents Of The University Of California Cornea preservation medium
JP2005306749A (ja) * 2004-04-19 2005-11-04 Kringle Pharma Inc Ｈｇｆ含有臓器保存液
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
IL273422B (en) 2004-10-07 2022-07-01 Transmedics Inc Methods and systems for extracorporeal organ treatment
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
PT2347775T (pt) 2005-12-13 2020-07-14 The President And Fellows Of Harvard College Estruturas em andaime para transplante celular
KR100809046B1 (ko) * 2006-03-10 2008-03-03 가톨릭대학교 산학협력단 풀루란을 가진 나노자가응집체 및 이의 이용방법
EP3103451A1 (fr) 2007-01-12 2016-12-14 University of Maryland, Baltimore Ciblage de canal ncca-atp destiné à protéger les organes après un épisode ischémique
WO2008100636A2 (fr) * 2007-02-17 2008-08-21 President And Fellows Of Harvard College Compositions et procédé de conservation de tissu
KR100834687B1 (ko) * 2007-02-21 2008-06-02 주식회사 엘지생활건강 히노키티올 함유 지질 나노 입자 및 그의 제조방법
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
KR100785656B1 (ko) * 2007-05-14 2007-12-17 재단법인서울대학교산학협력재단 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체
US9770535B2 (en) 2007-06-21 2017-09-26 President And Fellows Of Harvard College Scaffolds for cell collection or elimination
FR2919785B1 (fr) * 2007-08-09 2017-10-20 Hemarina Sa Utilisation d'une globine, d'un protomere de globine ou d'une hemoglobine extracellulaire pour la preservation d'organes, de tissus, ou de cellules d'organes ou de tissus, ou de culture de cellules
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
CA2715460C (fr) 2008-02-13 2020-02-18 President And Fellows Of Harvard College Dispositifs de programmation cellulaire continue
CN102574901B (zh) * 2009-05-07 2016-08-03 埃玛里纳 新的血红蛋白及其用途
US8389474B1 (en) * 2009-07-14 2013-03-05 Alan Anson Wanderer Rationale for IL-1 β targeted therapy to improve harvested organ viability, allograft tolerance, replant success and for conditions characterized by reduced or absent arterial perfusion
AU2010278702C1 (en) 2009-07-31 2016-07-14 Forsyth Dental Infirmary For Children Programming of cells for tolerogenic therapies
CN102812117B (zh) 2010-01-29 2014-03-19 株式会社器官再生工学 器官或组织的灌注培养方法以及灌注培养装置
CN103548811B (zh) * 2010-02-23 2016-02-24 泰尔茂株式会社 红血球浓厚液用添加剂以及医疗用容器
US11202759B2 (en) 2010-10-06 2021-12-21 President And Fellows Of Harvard College Injectable, pore-forming hydrogels for materials-based cell therapies
WO2012122318A2 (fr) * 2011-03-07 2012-09-13 Massachusetts Institute Of Technology Procédés pour transfecter des cellules avec des acides nucléiques
DK2704560T3 (da) 2011-04-14 2022-05-23 Transmedics Inc Organbehandlingsopløsning til maskinperfusion ex-vivo af donorlunger
EP2701745B1 (fr) 2011-04-28 2018-07-11 President and Fellows of Harvard College Échafaudages tridimensionnels macroscopiques préformés injectables pour l'administration minimalement invasive
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
GB201107466D0 (en) 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
JP6062426B2 (ja) 2011-06-03 2017-01-18 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ インサイチュー抗原生成癌ワクチン
KR20140099269A (ko) * 2011-11-11 2014-08-11 이센셜 파마수티컬스 엘엘씨 혈청 대체물질 및 불안정한 인자를 포함하는 키트
SI2838515T1 (sl) 2012-04-16 2020-07-31 President And Fellows Of Harvard College Mezoporozni sestavki iz silicijevega dioksida za moduliranje imunskih odgovorov
CN103461322B (zh) * 2012-06-07 2016-08-03 西比曼生物科技（上海）有限公司 用于冻存复苏后的细胞的保存液
KR101426804B1 (ko) * 2012-10-09 2014-08-05 김홍승 혈소판 보존 조성물, 이를 포함하는 혈소판 보존 키트 및 이를 이용한 혈소판 보존 방법
AU2013351058B2 (en) * 2012-11-30 2017-03-16 Pharmacosmos Holding A/S Cryoprotecting agent, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservation
CN105960165B (zh) * 2013-11-21 2021-03-23 李沙丹 基于聚合物的移植用保存溶液
WO2015095651A1 (fr) * 2013-12-20 2015-06-25 Essential Pharmaceuticals, Llc Milieux de culture cellulaire
TW202348234A (zh) 2013-12-24 2023-12-16 維吉尼亞聯邦大學 氧化膽固醇硫酸鹽（ｏｃｓ）之用途
CN103931607A (zh) * 2014-04-04 2014-07-23 湖南苗王生物科技有限公司 一种鲟鱼精子玻璃化冷冻方法
US10682400B2 (en) 2014-04-30 2020-06-16 President And Fellows Of Harvard College Combination vaccine devices and methods of killing cancer cells
DK3151663T3 (da) 2014-06-02 2020-11-30 Transmedics Inc Ex vivo-organplejesystem
KR101668743B1 (ko) * 2014-08-08 2016-10-25 (주)세포바이오 식물 유래 재조합 인간 혈청 알부민 및 식물성 펩타이드를 유효성분으로 함유하는 세포 보존용 조성물
CA2970117A1 (fr) 2014-12-12 2016-06-16 Darren FREED Appareil et procede de perfusion d'organe
US11786457B2 (en) 2015-01-30 2023-10-17 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
WO2016164705A1 (fr) 2015-04-10 2016-10-13 Omar Abdel-Rahman Ali Dispositifs de piégeage de cellules immunitaires et leurs procédés de fabrication et d'utilisation
EP3317395B1 (fr) 2015-06-30 2020-07-15 Société des Produits Nestlé S.A. Composition appropriée pour protéger des micro-organismes
CN105284786B (zh) * 2015-10-15 2017-12-05 广州赛莱拉干细胞科技股份有限公司 一种细胞保存液及其在保护巨核祖细胞活力中的应用
SG11201805533QA (en) * 2016-01-14 2018-07-30 Depuy Synthes Products Inc Composition and methods for cryopreservation of hutc
CN109072197A (zh) 2016-02-06 2018-12-21 哈佛学院校长同事会 重塑造血巢以重建免疫
CN108617639A (zh) * 2016-03-06 2018-10-09 李倩 一种人脂肪干细胞用的细胞冻存液
US11555177B2 (en) 2016-07-13 2023-01-17 President And Fellows Of Harvard College Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
CN106613148A (zh) * 2016-11-19 2017-05-10 蚌埠市涂山村富民石榴专业合作社 一种大棚蒜黄多次采收的种植方法
CN106689115A (zh) * 2016-11-30 2017-05-24 广州赛莱拉干细胞科技股份有限公司 一种脐带保存液及其应用
CN106434532A (zh) * 2016-12-22 2017-02-22 叶宗耀 一种培养肝细胞的培养基及其制备方法
CN106857501B (zh) * 2017-02-22 2021-09-24 单纯 用于保存大鼠肝匀浆s9的储存液及其制备方法
CN107041362B (zh) * 2017-05-23 2020-12-22 天晴干细胞股份有限公司 一种肿瘤组织块深低温冷冻方法
CN107624753A (zh) * 2017-09-19 2018-01-26 北京瑞格瑞特生物科技有限公司 一种细胞低氧稳压运输方法
US11590079B2 (en) 2018-01-18 2023-02-28 EndoProtech, Inc. Treating microvascular dysfunction
CA3129732A1 (fr) * 2019-02-14 2020-08-20 North Grove Investments, Inc. Compositions pour maintenir la viabilite d'un materiau biologique vivant et statique, leurs procedes de production et leurs utilisations
CN110012901B (zh) * 2019-04-12 2021-06-01 西北农林科技大学 一种用于猪精液常温保存的稀释制剂
KR102344674B1 (ko) * 2019-06-19 2021-12-29 가천대학교 산학협력단 8-옥소-2'-디옥시구아노신을 유효성분으로 포함하는 이식용 장기의 보존 시 장기손상 방지용 조성물
JPWO2021090869A1 (fr) * 2019-11-08 2021-05-14
WO2021173535A1 (fr) 2020-02-26 2021-09-02 Finless Foods Inc. Systèmes et procédés de conservation de tissus de poissons vivants
CN112514892B (zh) * 2020-12-25 2022-06-14 广州赛莱拉干细胞科技股份有限公司 一种外泌体冻存保护液及其制备方法
WO2023023309A1 (fr) 2021-08-20 2023-02-23 Finless Foods Inc. Systèmes et procédés de conservation de tissus de poisson
CN113973808A (zh) * 2021-11-15 2022-01-28 深圳市人民医院 一种改进的细胞冻存液配方
CN114600872A (zh) * 2022-04-13 2022-06-10 西安北光医学生物技术有限公司 一种细胞、组织或器官的抗损伤保存的方法及保存系统
CN114698630B (zh) * 2022-06-06 2022-08-23 天津百恩生物科技有限公司 一种胎盘组织保存液及其制备方法与应用
CN115349514B (zh) * 2022-07-08 2024-02-27 杭州联川生物技术股份有限公司 一种新鲜组织冻存液及其制备方法和应用

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1A (en) * 1836-07-13 John Ruggles Locomotive steam-engine for rail and other roads
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
JPS57194787A (en) * 1981-05-28 1982-11-30 Ajinomoto Co Inc Culture medium for animal cell
JPS5863385A (ja) * 1981-10-02 1983-04-15 ハナ・バイオロジツクス・インコ−ポレ−テツド 免疫系由来の細胞用培地
US4657866A (en) * 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
WO1986000227A1 (fr) 1984-06-22 1986-01-16 Veech Richard L Solutions electrolytiques et leur utilisation in vivo
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US4879283A (en) * 1985-10-03 1989-11-07 Wisconsin Alumni Research Foundation Solution for the preservation of organs
EP0283942B1 (fr) * 1987-03-24 1992-05-20 W.R. Grace & Co.-Conn. Milieu nutritif de base pour la culture de cellules
CA1315725C (fr) * 1987-07-24 1993-04-06 Duane Inlow Microemulsions de lipides pour milieu de culture
US5061481A (en) 1989-03-20 1991-10-29 Kobayashi Kose Co., Ltd. Cosmetic composition having acryl-silicone graft copolymer
CA2018228C (fr) * 1989-06-05 1996-02-27 Nancy L. Parenteau Systemes et milieu de culture cellulaire
JPH03180176A (ja) * 1989-11-16 1991-08-06 W R Grace & Co 細胞培養のための基礎栄養培地
US5066578A (en) * 1989-12-21 1991-11-19 The Regents Of The University Of California Long-term preservation of organs for transplantation
US5104787A (en) * 1990-03-05 1992-04-14 Lindstrom Richard L Method for apparatus for a defined serumfree medical solution useful for corneal preservation
JPH0728732B2 (ja) * 1990-04-17 1995-04-05 日本石油株式会社 動物細胞増殖促進剤及び無血清培地
JPH0459735A (ja) * 1990-06-27 1992-02-26 Terumo Corp ヘモグロビン含有リポソーム
JP2956998B2 (ja) * 1990-10-11 1999-10-04 テルモ株式会社 移植器官潅流保存液および移植器官潅流保存法
ATE195338T1 (de) * 1991-06-17 2000-08-15 Life Technologies Inc Technik zur konzentration von kulturmedien
WO1993009220A1 (fr) 1991-11-06 1993-05-13 Correa Paulo N Milieu de culture cellulaire
US6291424B1 (en) * 1991-11-14 2001-09-18 Brigham And Women's Hospital Nitrosated and nitrosylated heme proteins
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients
ATE194767T1 (de) 1992-03-23 2000-08-15 Univ Georgetown In liposomen verkapseltes taxol und verwendungsverfahren
US5370989A (en) 1992-04-03 1994-12-06 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5637315A (en) * 1993-01-04 1997-06-10 Thomas Jefferson University Treatment of disease states induced by oxidative stress
US5599659A (en) * 1993-03-11 1997-02-04 Breonics, Inc. Preservation solution for ex vivo, warm preservation of tissues, explants,organs and vascular endothelial cells comprising retinal-derived fibroblast growth factor, cyclodextrin and chondroitin sulfate
EP0804244A1 (fr) 1993-03-26 1997-11-05 Biorelease Technologies, Inc. Compositions comportant des proteines heminiques et methodes associees
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
DE69430805T2 (de) 1993-08-12 2003-02-13 University Of North Carolina At Chapel Hill, Chapel Hill Spüllösung für organe und gewebe
FR2709666B1 (fr) * 1993-09-07 1995-10-13 Oreal Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
US5428039A (en) 1994-02-20 1995-06-27 The Center For Innovative Technology Method for electively achieving reversible hyperpolarized cardiac arrest
US5543316A (en) * 1994-04-20 1996-08-06 Diacrin, Inc. Injectable culture medium for maintaining viability of myoblast cells
CN1200036A (zh) 1995-09-14 1998-11-25 Lxr生物技术有限公司 含有磷脂混合物并具有抗细胞程序死亡活性的组合物
US5670545A (en) 1996-02-09 1997-09-23 Board Of Regents Of The University Of Colorado Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species
US5897987A (en) * 1996-03-25 1999-04-27 Advanced Reproduction Technologies, Inc. Use of arabinogalactan in cell cryopreservation media
US5696152A (en) * 1996-05-07 1997-12-09 Wisconsin Alumni Research Foundation Taxol composition for use as organ preservation and cardioplegic agents
US5843024A (en) 1996-05-17 1998-12-01 Breonics, Inc. Solution and process for resuscitation and preparation of ischemically damaged tissue
CA2266744A1 (fr) 1996-09-27 1998-04-02 The Board Of Trustees Of The University Of Illinois Proteines d'hemes de liaison d'oxygene contenant des globines a permutation circulaire
US6274305B1 (en) * 1996-12-19 2001-08-14 Tufts University Inhibiting proliferation of cancer cells
WO1998041213A1 (fr) * 1997-03-19 1998-09-24 Lxr Biotechnology Inc. Compositions contenant des acides lysophosphotidiques inhibant l'apoptose, et leurs utilisations
US6495532B1 (en) 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US5834178C1 (en) * 1997-07-09 2002-04-23 Univ Wayne State Flush-storage solution for donor organs
US5948609A (en) * 1997-12-03 1999-09-07 Carter; Daniel C. Oxygen-transporting albumin-based blood replacement composition and blood volume expander
WO1999047922A2 (fr) * 1998-03-18 1999-09-23 Massachusetts Institute Of Technology Ensemble de micro-tissus et de micro-organes vascularises et perfuses
ATE372377T1 (de) * 1998-03-30 2007-09-15 Mibelle Ag Cosmetics Verwendung von nanoemulsionen zur bestimmung der biokompatibilität von lipophilen stoffen im zellkultur-test und dafür geeignete nanoemulsionen
JP4222658B2 (ja) * 1998-06-23 2009-02-12 テルモ株式会社 細胞支持基材、培養装置および液体処理装置
US6406909B1 (en) * 1998-07-10 2002-06-18 Chugai Seiyaku Kabushiki Kaisha Serum-free medium for culturing animal cells
US6204375B1 (en) * 1998-07-31 2001-03-20 Ambion, Inc. Methods and reagents for preserving RNA in cell and tissue samples
US6200590B1 (en) * 1998-08-10 2001-03-13 Naphcare, Inc. Controlled, phased-release suppository and its method of production
US6153582A (en) * 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
US6582953B2 (en) * 1999-04-14 2003-06-24 Breonics, Inc. Organ chamber for exsanguinous metabolic support system
FR2793495B1 (fr) * 1999-05-14 2001-08-10 Imv Technologies Dilueur pour la cryoconservation de spermatozoides de bovins
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US6670184B2 (en) * 2000-06-23 2003-12-30 Basf Ag Method for producing a lipid emulsion for use in insect cell culture
EP1305040B1 (fr) * 2000-07-28 2009-09-09 Christopher J. Murphy Milieu pour transplantation
US7198895B2 (en) * 2000-11-14 2007-04-03 Mohanlal Ramon W In vitro cell-based methods for biological validation and pharmacological screening of chemical entities and biologicals
WO2003017987A1 (fr) * 2001-08-31 2003-03-06 Mcgill University Nanocapsules polymeres biodegradables et utilisation de celles-ci
EP1475434A1 (fr) * 2003-05-09 2004-11-10 Oncoscience AG Procédé de stockage de cellules tumorales

Also Published As

Publication number Publication date
EP1624750B1 (fr) 2015-12-30
EP1624750A2 (fr) 2006-02-15
US7220538B2 (en) 2007-05-22
US20070042338A1 (en) 2007-02-22
JP4870551B2 (ja) 2012-02-08
BRPI0410185A (pt) 2006-05-16
WO2004101758A2 (fr) 2004-11-25
CN1816617B (zh) 2010-12-01
AU2004236402B2 (en) 2009-12-03
CA2526933C (fr) 2013-02-12
KR20060019525A (ko) 2006-03-03
CA2526933A1 (fr) 2004-11-25
MXPA05012070A (es) 2006-06-23
AU2004239310B2 (en) 2010-06-17
US20070178435A1 (en) 2007-08-02
CN1816617A (zh) 2006-08-09
JP5192694B2 (ja) 2013-05-08
RU2005138320A (ru) 2006-04-27
US20050037330A1 (en) 2005-02-17
CN1784142A (zh) 2006-06-07
EP1475434A1 (fr) 2004-11-10
US7604933B2 (en) 2009-10-20
WO2004101758A3 (fr) 2005-08-11
AU2004239310A1 (en) 2004-11-25
CA2523417A1 (fr) 2004-11-18
JP2007524368A (ja) 2007-08-30
EP1624750A4 (fr) 2006-10-25
AU2004236402A1 (en) 2004-11-18
WO2004099393A1 (fr) 2004-11-18
US7537885B2 (en) 2009-05-26
JP2007502130A (ja) 2007-02-08
CA2523417C (fr) 2013-04-30
EP1623021A1 (fr) 2006-02-08

Similar Documents

Publication Publication Date Title
ZA200509760B (en) Composition for maintaining organ and cell viability
EP1682150A4 (fr) Compositions et procedes pour induire la differenciation cellulaire
IL231889A0 (en) Preparations containing a dendritic cell and methods
EP1701729A4 (fr) Compositions de matrice osseuse ameliorees et methodes associees
EP1488816A4 (fr) Systeme de culture cellulaire ferme
GB0422525D0 (en) Dermatological compositions and methods
EP1570069A4 (fr) Compositions et procedes de dedifferentiation cellulaire et de regeneration de tissus
EP1654374A4 (fr) Processus et compositions de fermentation
IL211089A0 (en) Compositions and methods for cell killing
GB2404665B (en) Cell culture
EP1778219A4 (fr) Compositions d'ascophyllum et procedes
IL184062A0 (en) Visco-supplement composition and methods
EP1535514A4 (fr) Composition permettant de proteger un organe, un tissu ou des cellules et son procede d'utilisation
EP1731571A4 (fr) Agent solubilisant et composition contenant celui-ci
EP1871914A4 (fr) Procédés et compositions destinés à l'introduction de biopolymères dans des cellules
ZA200506732B (en) Cell culture
EP1781337A4 (fr) Procedes et compositions pour l'activation de cellules
PL1749090T3 (pl) Sposób formułowania i kompozycja do terapii komórkowej
AU2003240281A8 (en) Cell targeting methods and compositions
GB0425172D0 (en) Plant cells and uses thereof
AU2003230767A8 (en) Methods of promoting cell viability
EP1809736A4 (fr) Cryoconservation de cellules
EP1660633A4 (fr) Cellules souches piegees et leurs utilisations
EP1596815A4 (fr) Composition et technique destinees a inhiber la survie cellulaire
EP1596815A3 (fr) Composition et technique destinees a inhiber la survie cellulaire